Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
about
The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionStructural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and FluconazoleStructural Insights into Inhibition of Sterol 14 -Demethylase in the Human Pathogen Trypanosoma cruziBinding Modes of Zaragozic Acid A to Human Squalene Synthase and Staphylococcal Dehydrosqualene SynthaseCYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovaniDiverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51Trypanosoma cruzi response to sterol biosynthesis inhibitors: morphophysiological alterations leading to cell deathTargeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylaseSterol biosynthesis is required for heat resistance but not extracellular survival in leishmaniaTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelNovel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream formsSterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasisA Computational Methodology to Overcome the Challenges Associated With the Search for Specific Enzyme Targets to Develop Drugs Against Leishmania major.In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotesEssential multimeric enzymes in kinetoplastid parasites: A host of potentially druggable protein-protein interactions.Trypanosoma cruzi epimastigotes are able to store and mobilize high amounts of cholesterol in reservosome lipid inclusions.Drug strategies targeting CYP51 in neglected tropical diseasesIn vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.Identification of pathogenicity-related genes in the vascular wilt fungus Verticillium dahliae by Agrobacterium tumefaciens-mediated T-DNA insertional mutagenesisPotent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.Dynamics of sterol synthesis during development of Leishmania spp. parasites to their virulent form.Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cellsThe subcellular distribution of small molecules: from pharmacokinetics to synthetic biologyGene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis.Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis.Antileishmanial effect of mevastatin is due to interference with sterol metabolism.Δ(24)-Sterol Methyltransferase Plays an Important Role in the Growth and Development of Sporothrix schenckii and Sporothrix brasiliensis.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.New Promising Compounds with in Vitro Nanomolar Activity against Trypanosoma cruziRecent developments in trans-sialidase inhibitors of Trypanosoma cruzi.Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii.Sterols with antileishmanial activity isolated from the roots of Pentalinon andrieuxii.In vivo anti-Trypanosoma cruzi activity of hydro-ethanolic extract and isolated active principles from Aristeguietia glutinosa and mechanism of action studies.FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p.Mechanisms of growth inhibition of Phytomonas serpens by the alkaloids tomatine and tomatidine.Toxicity and Loss of Mitochondrial Membrane Potential Induced by Alkyl Gallates in Trypanosoma cruzi.Liposomal formulation of turmerone-rich hexane fractions from Curcuma longa enhances their antileishmanial activity.Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpeneSynthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis.
P2860
Q26829884-FA9D3210-9879-4538-B234-34D067FD31E3Q27660510-09C241C8-8DF9-470C-8211-9CACC6831CF8Q27662136-EDF988EC-B4CF-4EE2-82FB-EFF9B7C3164EQ27678314-6DAAFE2F-EF76-4E81-9947-15304D6C2FA4Q28477209-2BFD2820-DAFC-4F19-A95D-F1F18645E76DQ28481694-5DCE0B0F-C9F7-4015-88E5-8CAC2ED3BE0BQ28485411-B8E5AC23-1957-4BFC-8A60-0B579F1507D1Q28544037-CE39EA16-BB17-468D-97F0-3E9C83781131Q28544093-7CBE5A86-0A98-4509-9BA3-E90960A4A1C0Q28553573-21F95AD4-6106-4D3B-9339-B6A78BE5F3B3Q28714212-BAF44AE7-08ED-402C-8AF4-F60CD240EB13Q28727454-F3E52377-AF6B-4A1C-8115-BE092DABE7A0Q33797941-945CD39A-8E0D-4E3C-892F-A35A2A4CFAF4Q33853773-66AAE079-56EF-4203-AFCF-8EA5711475B3Q33898663-828B6826-3910-4AB1-87A8-5A18537C8F8CQ33983190-DCD70E98-33FD-4FEB-877D-311E7AB96EF2Q34622554-F791B156-363C-470C-9025-4D1ECB891476Q35077994-2B13B03C-73EB-4840-B507-89409C5913C7Q35243128-5C4D187A-9708-4D22-8E8B-F0F09951D310Q36075944-71EEDE94-BE05-4131-98D9-9038FF144B34Q36793673-D07279E3-34D3-4866-8852-AED636B988DFQ37198743-597A40BF-FDCC-45E3-9B76-0290EAED5B86Q37909301-1A7B7DBF-19DD-419A-9FBA-2B59EEA7826BQ38286350-8109B178-6E5C-422F-A2F6-8A3C1BC2E5ABQ38518717-1E2A9CFC-2B20-433E-9112-F155F08E72D7Q38805947-A79897FF-D2CB-41E6-B1F5-C76530C40E59Q38852074-8D8B7877-F3F5-44A0-9838-C5B9614DE707Q38913538-3CA3E92C-A3AB-4635-9DB2-D5A2D7A93A74Q38939544-9EED4E2F-8E2F-4384-AA3A-62D5AE7E33F3Q39012627-66D90F5E-38BF-4BA5-9637-31EE2CD0CC31Q39111617-B0D0A0A1-7F79-4FC1-ABEC-6809402B35F3Q39220490-A1FED446-4A48-453B-9239-37752B16B357Q39307254-F6FBB95C-AFD3-4496-A16C-085AA2DAD064Q39554107-9C37BF33-3652-40D5-A33F-D4ED704A1678Q41234890-D91AC566-0D12-4D95-9B3D-0FC0486A00B5Q41836534-BE677800-2C94-4484-AD28-771CCA1E91C7Q41983753-827EC781-68F4-499D-BC14-5A5B9E24C816Q42017568-ECA43C40-5735-45C2-9F11-6C19D18FC59AQ42109679-78185BCC-F747-4402-AC90-1789AC36C18DQ42255891-07D8E0DB-74CD-4905-A02A-03C5FC7C8904
P2860
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@en
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@nl
type
label
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@en
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@nl
prefLabel
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@en
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@nl
P2860
P356
P1476
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
@en
P2093
Juliany Cola Fernandes Rodrigues
Wanderley de Souza
P2860
P304
P356
10.1155/2009/642502
P577
2009-08-05T00:00:00Z